Cargando…
Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371707/ https://www.ncbi.nlm.nih.gov/pubmed/37502593 http://dx.doi.org/10.1155/2023/9781753 |
_version_ | 1785078208082739200 |
---|---|
author | Markers, Disease |
author_facet | Markers, Disease |
author_sort | Markers, Disease |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10371707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-103717072023-07-27 Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma Markers, Disease Dis Markers Retraction Hindawi 2023-07-19 /pmc/articles/PMC10371707/ /pubmed/37502593 http://dx.doi.org/10.1155/2023/9781753 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Retraction Markers, Disease Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma |
title | Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma |
title_full | Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma |
title_fullStr | Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma |
title_full_unstemmed | Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma |
title_short | Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma |
title_sort | retracted: the higher expression of cdca2 associated with poor prognosis in glioma |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371707/ https://www.ncbi.nlm.nih.gov/pubmed/37502593 http://dx.doi.org/10.1155/2023/9781753 |
work_keys_str_mv | AT markersdisease retractedthehigherexpressionofcdca2associatedwithpoorprognosisinglioma |